VK

Vipul Kumar Goel

Active Director Director DIN 01892257
DIN 01892257 First appointment Nov 2007 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 3 historical roles
Total affiliations 5 Since Nov 2007
Shareholding value •••• Premium profile

About Vipul Kumar Goel

Data last updated:

Vipul Kumar Goel is a Director at Medivs Biosciences Private Limited (since 2022) and Director at Parth Orgichem Private Limited (since 2013). The companies operate in Pharma, Chemicals and Materials and Business Services. The 2 current companies with reported revenue have a combined latest revenue of ₹9.97 Cr; the largest is Medivs Biosciences Private Limited at ₹6.07 Cr (FY 2025). Earlier, Vipul Kumar Goel was a Director at Svipt Life Sciences Private Limited (2018–2024) and Director at Orchid Bio-Tech Limited (2007–2011) and 1 more.

DIN 01892257
Primary Designation Director
Industry Pharma
First Appointment 20 Nov 2007
Oldest Company Age 12 yrs
Largest company Medivs Biosciences Private Limited · ₹6.07 Cr (FY 2025)
Combined revenue ₹9.97 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medivs Biosciences Private Limited U46901UP2022PTC161621
Director31 Mar 20222022₹6.07 Cr (FY 2025)Active
Parth Orgichem Private Limited U24100UP2013PTC061565
Director27 Dec 20132013₹3.89 Cr (FY 2021)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Svipt Life Sciences Private Limited U74999UP2018PTC110192
Director12 Nov 20182018Active
Orchid Bio-Tech Limited U24231DL2005PLC133511
Director01 Dec 20072005₹22.90 Cr (FY 2025)Active
Staywell Formulation Private Limited U24233DL2007PTC170595
Director20 Nov 20072007₹3.5 Lakh (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Vipul Kumar Goel

NameDINCompanyDesignation
Shruti Goel06759659Medivs Biosciences Private LimitedDirector
Rita Goel10542357Parth Orgichem Private LimitedDirector

Directorship timeline

Open interactive timeline →
Parth Orgichem Private Limited
Medivs Biosciences Private Limited
Svipt Life Sciences Private Limited
Orchid Bio-Tech Limited
Premium access

Shareholding and investment profile for Vipul Kumar Goel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vipul Kumar Goel

Vipul Kumar Goel currently holds 2 directorships: Medivs Biosciences Private Limited (Director, since 31 Mar 2022, revenue ₹6.07 Cr (FY 2025)); Parth Orgichem Private Limited (Director, since 27 Dec 2013, revenue ₹3.89 Cr (FY 2021)).

Vipul Kumar Goel was first appointed on 20 Nov 2007 as Director at Staywell Formulation Private Limited. The most recent appointment on record is 31 Mar 2022 at Medivs Biosciences Private Limited.

The 2 current companies of Vipul Kumar Goel that report revenue have a combined latest revenue of ₹9.97 Cr: Medivs Biosciences Private Limited ₹6.07 Cr (FY 2025); Parth Orgichem Private Limited ₹3.89 Cr (FY 2021).

Vipul Kumar Goel held 3 earlier board appointments: Svipt Life Sciences Private Limited (Director, 12 Nov 2018 to 11 Mar 2024); Orchid Bio-Tech Limited (Director, 01 Dec 2007 to 05 Sep 2011); Staywell Formulation Private Limited (Director, 20 Nov 2007 to 10 Nov 2008).

The current boards of Vipul Kumar Goel's companies include Shruti Goel (Medivs Biosciences Private Limited), Rita Goel (Parth Orgichem Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available